Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/biopure-receives-notice-of-nasdaq-delisting-50386-1/;+health+history;+medical+history.html) was not found.

Search medicine news 1 biopure receives notice of nasdaq delisting 50386 1 ;+health+history;+medical+history html at Google

Search medicine news 1 biopure receives notice of nasdaq delisting 50386 1 ;+health+history;+medical+history html at Yahoo

Search medicine news 1 biopure receives notice of nasdaq delisting 50386 1 ;+health+history;+medical+history html at Msn

Google
 
(Date:12/3/2009)... to learn new information and adapt to changes in our ... to lie in the minute junctions where nerve cells communicate, ... researchers. The study is published online this week in the ... Wen-Biao Gan, PhD, associate professor of physiology and neuroscience at ...
(Date:12/3/2009)... scientists believe that staph infections are caused by many bacterial ... process is called quorum sensing because many bacteria must be ... research group has determined that the very first stage of ... virulent form, occurs in a single cell and that this ...
(Date:12/3/2009)... Spanish researchers have measured CO2 levels for the past ... sparsely inhabited rural area near Valladolid. The results, which ... Peninsula, show that the levels rose "significantly" between 2002 ... have been trying to find out about carbon dioxide ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 1Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 2Progressive Groups to Spend More Than 2482 Million to Ensure Real Health Care Reform Passes This Year 47516 3Niutang Sucralose Patent Litigation Successfully Concluded 47514 1Niutang Sucralose Patent Litigation Successfully Concluded 47514 2Niutang Sucralose Patent Litigation Successfully Concluded 47514 3Michael J Fox Foundation Announces Launch of PD Online Research 47512 1Michael J Fox Foundation Announces Launch of PD Online Research 47512 2Michael J Fox Foundation Announces Launch of PD Online Research 47512 3
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...
(Date:12/5/2009)... with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) ... birthday without ever tying the knot, since research has shown ... And, um, isn,t there something wrong with those who go ... study looking at psychological measures shows that never-married people aged ...
(Date:12/5/2009)... an innovative new international private medical insurance plan which follows the ... customers the flexibility to add or remove a wide range of ... to tailor their benefits to complement those already offered in their ... ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... spin filters allow for the rapid isolation of ... DNA gel slice in the spin filter, centrifuge ... DNA is recovered. There is no need to ... Spin filters can also be used for buffer ...
Request Info...
...
Request Info...
Biology Products:
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Extra-large 3.2mm channel allows excellent suction with EndoTherapy devices in place....
... bronchofiberscope yet. The BF-3C40's distal end measures ... the previous model. It also offers better ... to the use of extra-fine optical fibers ... size by 70 percent. Images are clearer, ...
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
Medicine Products:
(Date:12/4/2009)... and Technology (NIST) and the Naval Research Laboratory have ... a semiconductor crystal by prodding it with a scanning ... technique will enable researchers to selectively implant atoms in ... its electrical and magnetic properties on the atomic scale. ...
(Date:12/4/2009)... Alberta Centre for Advanced Micro Nano Technology Products ... seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ... how technologies like nanotechnology, biomaterials and microfluidics can ... innovative healthcare products that help promote health and ...
(Date:12/4/2009)... Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin ... fuel paradigm through the production of ethanol from non-food cellulosic ... Digest list of the "50 Hottest Companies in Bioenergy;" ... ,, "Having voters rank BlueFire Ethanol among the top 20 ...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3
(Date:12/4/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today ... the company,s Phase II-b, dose escalation, clinical trial in ... injury (TBI). Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic ... in improving the outcome of patients with severe TBI. ...
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, announced today the presentation of new data ... lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine is ... temperatures up to and including 55 degrees C. ...
(Date:12/4/2009)... stored in tin cans and car trunks ,, ... urged the Senate to defeat the Dorgan Importation plan encompassed ... importation amendment is poised to open our borders, allowing our ... to be endangered. We could soon be getting drugs ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 1Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 2Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 3ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML 47509 1ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML 47509 2Dont mistake an athlete for a toxic jock 47507 1Dont mistake an athlete for a toxic jock 47507 2